Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Ernesto, Schinzari, Giovanni, Zizzari, Ilaria Grazia, Maiorano, Brigida Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Fiorentino, Vincenzo, Petrone, Gianluigi, Cassano, Alessandra, Rindi, Guido, Bria, Emilio, Blasi, Maria Antonietta, Nuti, Marianna, Tortora, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721347/
https://www.ncbi.nlm.nih.gov/pubmed/31357439
http://dx.doi.org/10.3390/cancers11081055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721347/
https://www.ncbi.nlm.nih.gov/pubmed/31357439
http://dx.doi.org/10.3390/cancers11081055

Ejemplares similares